Differential expression of human ferritin H chain gene in immortal human breast epithelial MCF-10F cells

Molecular Carcinogenesis

Volumn 20, Issue 4, 1997, Pages 332-339

  Higgy, Nadia A ^a   Salicioni, Ana M ^a   Russo, Irma H ^a   Zhang, Pei Li ^a   Russo, Jose ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast epithelial cells; Ferritin; Immortalization; Subtractive hybridization

Indexed keywords

COMPLEMENTARY DNA; FERRITIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL IMMORTALIZATION; DNA STRAND BREAKAGE; GENE SEQUENCE; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NORTHERN BLOTTING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; TRANSCRIPTION REGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0031425358     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199712)20:4<332::AID-MC2>3.0.CO;2-L     Document Type: Article

References (54)

1. Russo J, Barnabas N, Higgy N, Salicioni AM, Wu YL, Russo IH. Molecular basis of human breast epithelial cell transformation. In: Calvo F, Crepin M, Magdalenat H (eds), Breast Cancer, Advances in Biology and Therapeutics. John Libbey Eurotext, 1996, pp. 33-43.
2. Russo J, Rivera R, Russo IH. influence of age and parity on the development of the human breast. Breast Cancer Res Treat 23:211-218, 1992.
3. Russo J, Calaf G, Sohi N, et al. Critical steps in breast carcinogenesis. Ann New York Acad Sci 698:1-20, 1993.
4. Soule HD, Maloney TM, Wolman SR, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10F. Cancer Res 50:6075-6086, 1990.
5. Tait L, Soule H, Russo J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6087-6099, 1990.
6. Hackett AJ, Smith TS, Springer EL, et al. Two syngeneic cell lines from human breast tissue: The aneuploid mammary epithelial (Hs 578T) and the diploid myoepithelial (Hs 578BsT) cell lines. J Natl Cancer lnst 58:1795-1806, 1977.
7. Briand P, Petersen OW, van Dews B. A new diploid non-tumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev Biol 23:181-188, 1987.
8. Chang SE, Keen J, Lane EB, Taylor-Papadimitriou J. Establishment and characterization of SV-40 transformed human breast epithelial cell lines. Cancer Res 42:2040-2053, 1982.
9. Caron de Frontemel C, Nardeux PC, Soressi T, et al. Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbors SV-40 genetic information. Exp Cell Res 16:83-94, 1990.
10. Band V, Zajchowski D, Kulesa V, Sager R. Human papilloma virus DNA immortalize normal human mammary epithelial cells and reduce the growth factor requirements. Proc Natl Acad Sci USA 87:463-467, 1990.
11. Stampfer MR, Bartley JC. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after benz[a]pyrene. Proc Natl Acad Sci USA 82:2394-2398, 1984.
12. Bond JA, Wyllie FS, Wynford-Thomas D. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 7:1885-1888, 1994.
13. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B. Multifactorial analysis of p53 alterations in human cancer: A review. lnt J Cancer 57:1-9, 1994.
14. Barnabas N, Moraes R, Calaf G, Estrada S, Russo J. Role of p53 in MCF-10F cell immortalization and chemically-induced neoplastic transformation. International Journal of Oncology 7:1289-1296, 1995.
15. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
16. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer lnst 87:884-894, 1995.
17. Starkey CR, Levy LS. Identification of differentially expressed genes in T-lymphoid malignancies in an animal model system. lnt J Cancer 62:325-331, 1995.
18. Byrne JA, Tomasetto C, Garnier JM, et al. A screening method to identify genes commonly overexpressed in carcinomas and the identification of complementary DNA sequence. Cancer Res 55:2896-2903, 1995.
19. Swisshelm K, Ryan K, Tsuchiya K, Sager R. Enhanced expression of an insulin growth factor-like binding protein (mac 25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci USA 92:4472-4476, 1995.
20. Liang P, Averboukh L, Keyomarsi K, Sager R, Pardee A. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res 52:6966-6968, 1992.
21. Lee SW, Tomasetto C, Sager R. Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA 88:2825-2829, 1991.
22. Zou Z, Anisovic A, Hendrix MJ, et al. Identification of a novel serpin with tumor suppressing activity in human mammary epithelial cells. Science 263:526-529, 1994.
23. Scott MD, Westphal HH, Rigby RWJ. Activation of mouse genes in transfected cells. Cell 34:557-567, 1983.
24. Hendrick SM, Cohen D, Nielsen EA, Davis MM. Isolation of cDNA clones encoding T cell-specific membrane associated proteins. Nature 308:149-153, 1984.
25. Calaf G, Russo J. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14:483-492, 1993.
26. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162:156-159, 1987.
27. Maniatis T, Fritsch EF, SambrookJ. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989.
28. Lee TH, Lee GW, Ziff EB, Vilcek J. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol Cell Biol 10:1982-1988, 1990.
29. Boyd D, Vecoli C, Belcher DM, Jain SK, Drysdale JW. Structural and functional relationships of human ferritin H and L chains deduced from cDNA clones. J Biol Chem 260:11755-11761, 1985.
30. Costanzo F, Santoro C, Colantuoni V, et al. Cloning and sequencing of a full length cDNA coding for a human apoferritin H chain: Evidence for a multigene family. EMBO J 3:23-27, 1984.
31. Anison P. Current concepts in iron metabolism. Clin Lab Haematol 11:241-257, 1982.
32. Richard P, Ehrenberg A. Ribonucleotide reductase: A radical enzyme. Science 221:514-519, 1983.
33. Ponka P, Schulman HM, Cox TM. Iron metabolism in relation to heme synthesis. In: Dailey HA (ed), Biosynthesis of Heme and Chlorophyllus. McGraw-Hill, New York, 1990, pp. 393-405.
34. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 12:417-427, 1992.
35. Guyton KZ, Kensler TW. Oxidative mechanisms in carcinogenesis. Br Med Bull 49:523-533, 1993.
36. Malins DC, Holmes EH, Polissar NL, Gunselman SJ. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 71:3036-3043, 1993.
37. Theil EC. Ferritin: Structure, gene regulation, and cellular function in animals, plants and microorganisms. Annu Rev Biochem 56:289-315, 1987.
38. Klausner RD, Rouault TA, Harford JB. Regulating the fate of mRNA: The control of cellular iron metabolism. Cell 72:19-28, 1993.
39. Dognin J, Crichton RR. Mobilization of iron from ferritin fractions of defined iron content by biological reductants. FEBS Lett 54:234-236, 1973.
40. Biemond P, Swaak AJG, Beindorf CM, Koster JF. Superoxide dependent and independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Biochem J 239:169-173, 1986.
41. Zhao MJ, Jung L, Tanielian C, Mechin R. Kinetics of the competitive degradation of deoxyribose and other biomolecules by hydroxyl radicals produced by the Fenton reaction. Free Radic Res 20:345-363, 1994.
42. Fidler IJ, Nicolson GL. Concepts and mechanisms of breast cancer metastasis. In: Bland Kl, Copeland EM (eds), The Breast: Comprehensive Management of Benign and Malignant Diseases. Saunders, Philadelphia, 1991, pp. 395-408.
43. Kohn EC, Liotta LA. Molecular insights into cancer invasion: Strategies for prevention and intervention. Cancer Res 55:1856-1862, 1995.
44. Malins DC, Polissar NL, Gunselman SJ. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc Natl Acad Sci USA 93:2557-2563, 1996.
45. Han X, Liehr JG. Microsome mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: Correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis 16:2571-2574, 1995.
46. Frenkel K, Wei L, Wei H. 7,12-dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radic Biol Med 19:373-380, 1995.
47. Weinberg ED. Iron and neoplasia, Biol Trace Elem Res 3:55-80, 1981.
48. Fan H, Villegas C, Wright JA. A link between ferritin gene expression and ribonucleotide reductase R2 protein, as demonstrated by retroviral vector mediated stable expression of R2 cDNA. FEBS Lett 382:145-148, 1996.
49. Moroz C, Lahat N, Biniaminov M, Ramot B. Ferritin on the surface of lymphocytes of Hodgkin's disease patients: A possible blocking substance removed by levamisole. Clin Exp lmmunol 29:30-34, 1977.
50. Keown P, Descaps-Latscha B. In vitro suppression of cell mediated immunity by ferroproteins and ferric salts. Cell lmmunol 80:257-266, 1983.
51. Rosen HR, Moroz C, Reiner A, et al. Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer. Breast Cancer Res Treat 24:17-26, 1992.
52. Rosen HR, Flex D, Stierer M, Moroz C. Monoclonal antibody CMH-9 detects placental isoferritin in the serum of patients with visceral metastases of breast cancer. Cancer Lett 59:145-151, 1991.
53. Kwak EL, Larochelle DA, Blaumont C, Torti SV, Torti FM. Role of NF-KB in the regulation of ferritin H by tumor necrosis factor-α. J Biol Chem 270:15285-15293, 1995.
54. Rogers JT. Ferritin translation by interleukin-1 and interleukin-6: The role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 87:2525-2537, 1996.